- Home
- LUNG vs NCZ Comparison
LUNG vs NCZ Comparison
Compare LUNG & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- NCZ
- Stock Information
- Founded
- LUNG 1995
- NCZ 2003
- Country
- LUNG United States
- NCZ United States
- Employees
- LUNG N/A
- NCZ N/A
- Industry
- LUNG Industrial Specialties
- NCZ Finance Companies
- Sector
- LUNG Health Care
- NCZ Finance
- Exchange
- LUNG Nasdaq
- NCZ Nasdaq
- Market Cap
- LUNG 248.0M
- NCZ 232.2M
- IPO Year
- LUNG 2020
- NCZ N/A
- Fundamental
- Price
- LUNG $7.30
- NCZ $3.13
- Analyst Decision
- LUNG Strong Buy
- NCZ
- Analyst Count
- LUNG 7
- NCZ 0
- Target Price
- LUNG $13.71
- NCZ N/A
- AVG Volume (30 Days)
- LUNG 240.7K
- NCZ 533.0K
- Earning Date
- LUNG 10-28-2024
- NCZ 01-01-0001
- Dividend Yield
- LUNG N/A
- NCZ 12.16%
- EPS Growth
- LUNG N/A
- NCZ N/A
- EPS
- LUNG N/A
- NCZ N/A
- Revenue
- LUNG $76,583,000.00
- NCZ N/A
- Revenue This Year
- LUNG $22.73
- NCZ N/A
- Revenue Next Year
- LUNG $19.02
- NCZ N/A
- P/E Ratio
- LUNG N/A
- NCZ N/A
- Revenue Growth
- LUNG 26.26
- NCZ N/A
- 52 Week Low
- LUNG $5.46
- NCZ $2.50
- 52 Week High
- LUNG $14.84
- NCZ $3.15
- Technical
- Relative Strength Index (RSI)
- LUNG 41.60
- NCZ 65.70
- Support Level
- LUNG $7.18
- NCZ $3.06
- Resistance Level
- LUNG $8.59
- NCZ $3.11
- Average True Range (ATR)
- LUNG 0.40
- NCZ 0.04
- MACD
- LUNG -0.16
- NCZ 0.00
- Stochastic Oscillator
- LUNG 7.74
- NCZ 95.83
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas and consumable fuels and others.